KB 130015

Drug Profile

KB 130015

Latest Information Update: 21 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Karo Bio
  • Class Benzofurans; Carboxylic acids; Class III antiarrhythmics; Iodobenzenes; Small molecules
  • Mechanism of Action Thyroid hormone receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Arrhythmias

Most Recent Events

  • 12 Mar 2002 A study has been added to the Arrhythmias pharmacodynamics section
  • 12 May 2000 KB 130015 is available for licensing (http://www.karobio.se)
  • 03 Jun 1999 Preclinical development for Arrhythmias in Sweden (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top